Cyagen is a leading global provider of genetically modified rodent models and innovative cell and gene therapy solutions for research and development (R&D). With over 15 years of experience, we offer one-stop solutions for disease model development, AAV discovery, drug efficacy studies, and more. Our "AI+CGT" platform combines wet-lab experiments, bioinformatics, and AI to accelerate CGT research, including the identification and optimization of AAV vectors and CAR-T cell therapies. The Cyagen Knockout Catalog Models repository provides a vast resource of KO/cKO mouse strains for diverse research fields. We specialize in expertly customized mouse models using CRISPR gene editing, TurboKnockout, and transgenic technologies. Additionally, our Rare Disease Data Center (RDDC) offers AI-enabled bioinformatics tools for rare disease research, providing comprehensive genetic data visualization and pathogenic analysis tools.